JP2022108241A5 - - Google Patents

Download PDF

Info

Publication number
JP2022108241A5
JP2022108241A5 JP2021055886A JP2021055886A JP2022108241A5 JP 2022108241 A5 JP2022108241 A5 JP 2022108241A5 JP 2021055886 A JP2021055886 A JP 2021055886A JP 2021055886 A JP2021055886 A JP 2021055886A JP 2022108241 A5 JP2022108241 A5 JP 2022108241A5
Authority
JP
Japan
Prior art keywords
alkyl
tautomer
compound
occurrence
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021055886A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022108241A (ja
JP7611045B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2021/071256 external-priority patent/WO2022150962A1/en
Application filed filed Critical
Publication of JP2022108241A publication Critical patent/JP2022108241A/ja
Publication of JP2022108241A5 publication Critical patent/JP2022108241A5/ja
Application granted granted Critical
Publication of JP7611045B2 publication Critical patent/JP7611045B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021055886A 2021-01-12 2021-03-29 プロテアーゼ阻害剤、その調製、および使用 Active JP7611045B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2021/071256 WO2022150962A1 (en) 2021-01-12 2021-01-12 Protease inhibitors, preparation, and uses thereof
CNPCT/CN2021/071256 2021-01-12

Publications (3)

Publication Number Publication Date
JP2022108241A JP2022108241A (ja) 2022-07-25
JP2022108241A5 true JP2022108241A5 (cg-RX-API-DMAC7.html) 2022-09-20
JP7611045B2 JP7611045B2 (ja) 2025-01-09

Family

ID=75277880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021055886A Active JP7611045B2 (ja) 2021-01-12 2021-03-29 プロテアーゼ阻害剤、その調製、および使用

Country Status (5)

Country Link
US (1) US11958830B2 (cg-RX-API-DMAC7.html)
EP (1) EP4026830A1 (cg-RX-API-DMAC7.html)
JP (1) JP7611045B2 (cg-RX-API-DMAC7.html)
CN (2) CN113072497B (cg-RX-API-DMAC7.html)
WO (1) WO2022150962A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019216264B2 (en) 2018-01-31 2023-08-31 Heparegenix Gmbh Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
WO2019243315A1 (en) 2018-06-21 2019-12-26 Heparegenix Gmbh Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
SG11202012732UA (en) 2018-07-16 2021-02-25 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
JP7629442B2 (ja) 2019-07-29 2025-02-13 ヘパリジェニックス ゲーエムベーハー 肝臓再生を促進または肝細胞死を縮減もしくは防止するためのヘテロアリール置換ピラゾロ-ピリジンタンパク質キナーゼ阻害剤
CA3164361A1 (en) 2020-01-15 2021-07-22 Heparegenix Gmbh 3-benzoyl-1h-pyrrolo[2,3-b]pyridine derivatives as mkk4 inhibitors for treating liver diseases
JP2024178473A (ja) * 2021-09-03 2024-12-25 塩野義製薬株式会社 ウイルス増殖阻害活性を有する二環性含窒素複素環誘導体およびそれらを含有する医薬組成物
WO2023036140A1 (zh) 2021-09-07 2023-03-16 上海齐鲁制药研究中心有限公司 3CLpro蛋白酶抑制剂
CR20250040A (es) 2022-08-05 2025-03-18 Gilead Sciences Inc Inhibidores de la proteasa principal de sars-cov2
US20240158368A1 (en) 2022-10-14 2024-05-16 Abbvie Inc. Pyrrolidine Main Protease Inhibitors as Antiviral Agents
WO2024124287A1 (en) * 2022-12-12 2024-06-20 The Walter And Eliza Hall Institute Of Medical Research Compounds for treating viral infection
CN120787158A (zh) * 2023-03-03 2025-10-14 齐鲁动物保健品有限公司 3CLpro蛋白酶抑制剂在制备治疗猫冠状病毒疾病药物中的用途
JP2026515483A (ja) * 2023-04-11 2026-05-18 ウエストレイク ファーマシューティカルズ (ハンチョウ) カンパニー、リミテッド プロテアーゼ阻害剤及びその使用
WO2024243841A1 (zh) 2023-05-31 2024-12-05 西湖制药(杭州)有限公司 一种病毒蛋白酶抑制剂的结晶及用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175069B1 (da) * 1986-03-11 2004-05-24 Hoffmann La Roche Pyrocatecholderivater
US6335350B1 (en) 1998-12-09 2002-01-01 American Home Products Corporation Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
CN1333750A (zh) * 1998-12-09 2002-01-30 美国家庭用品有限公司 含乙酰胺和取代的乙酰胺的疱疹病毒硫脲抑制剂
EP1137632B1 (en) * 1998-12-09 2004-07-28 Wyeth Thiourea inhibitors of herpes viruses
TW200306159A (en) 2002-03-19 2003-11-16 Du Pont Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
DE10306250A1 (de) 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7067529B2 (en) 2003-05-19 2006-06-27 Hoffmann-La Roche Inc. Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
EP1652525A4 (en) * 2003-07-15 2008-10-01 Arigen Inc ANTI-VIRUS CORONA DRUG
US7732446B1 (en) * 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
JP2008532933A (ja) * 2005-02-11 2008-08-21 コーリー ファーマシューティカル グループ,インコーポレイテッド 置換イミダゾキノリン類および置換イミダゾナフチリジン類
EP2124568A1 (en) * 2007-01-17 2009-12-02 Merck & Co., Inc. Decahydroquinoline analogs as cb2 receptor modulators
CN101519372B (zh) * 2009-04-01 2011-07-20 深圳市盛捷生物技术有限公司 用作GSK3抑制剂的苯并[e]异吲哚-1,3-二酮化合物及其制备
WO2011151423A1 (en) 2010-06-04 2011-12-08 Exonhit S.A. Substituted isoquinolines and their use as tubulin polymerization inhibitors
WO2012090177A2 (en) * 2010-12-30 2012-07-05 Lupin Limited Cannabinoid receptor modulators
US9206128B2 (en) 2011-11-18 2015-12-08 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
WO2013075084A1 (en) 2011-11-18 2013-05-23 Constellation Pharmaceuticals Modulators of methyl modifying enzymes, compositions and uses thereof
WO2013078320A1 (en) 2011-11-21 2013-05-30 Constellation Pharmaceuticals Modulators of methyl modifying enzymes, compositions and uses thereof
CN104334532B (zh) * 2012-01-30 2018-08-14 霍夫曼-拉罗奇有限公司 异喹啉和二氮杂萘衍生物
US9085583B2 (en) 2012-02-10 2015-07-21 Constellation—Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
IN2014MN01982A (cg-RX-API-DMAC7.html) * 2012-04-25 2015-07-10 Raqualia Pharma Inc
WO2014025651A1 (en) 2012-08-06 2014-02-13 Amgen Inc. Chroman derivatives as trpm8 inhibitors
PL2953941T3 (pl) 2013-02-11 2017-11-30 Constellation Pharmaceuticals, Inc. Modulatory enzymów modyfikujących metyl, ich kompozycje i zastosowania
US9745305B2 (en) 2013-03-15 2017-08-29 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
US9969716B2 (en) 2013-08-15 2018-05-15 Constellation Pharmaceuticals, Inc. Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof
KR101715090B1 (ko) * 2013-08-28 2017-03-13 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
KR20150027922A (ko) 2013-09-04 2015-03-13 주식회사 대웅제약 신규한 항진균성 피리디닐하이드라자이드 유도체
WO2016036638A1 (en) * 2014-09-05 2016-03-10 Merck Sharp & Dohme Corp. Isoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
WO2017053604A1 (en) 2015-09-23 2017-03-30 The Regents Of The University Of California Potent antiviral pyrazolopyridine compounds
EP4006012A1 (en) * 2015-10-15 2022-06-01 Cornell University Proteasome inhibitors and uses thereof
EP3478662B1 (en) * 2016-06-30 2020-09-16 ViiV Healthcare UK (No.5) Limited Azadecalin derivatives as inhibitors of human immunodeficiency virus replication
CN107674029A (zh) * 2016-08-02 2018-02-09 上海迪诺医药科技有限公司 多环化合物、其药物组合物及应用
US11247970B2 (en) 2017-03-22 2022-02-15 Dana-Farber Cancer Institute, Inc. Selective inhibition of gluconeogenic activity
TWI821343B (zh) 2018-07-27 2023-11-11 美商共結晶製藥公司 流感病毒複製之抑制劑
MA53721A (fr) 2018-09-28 2021-09-15 Janssen Pharmaceutica Nv Modulateurs de la monoacylglycérol lipase
EP3982954A4 (en) * 2019-06-14 2024-01-03 The Trustees of Columbia University in the City of New York NT5C2 INHIBITORS FOR THE TREATMENT OF CHEMOTHERAPY-RESISTANT ACUTE LYMPHOBLASTIC LEUKEMIA

Similar Documents

Publication Publication Date Title
CA2465117A1 (en) Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
JP2022522694A5 (cg-RX-API-DMAC7.html)
JP2004500426A5 (cg-RX-API-DMAC7.html)
ME00354B (me) Novi lekovi za tretiranje hronićnog opstruktivnog oboljenja pluća
BRPI0212894B1 (pt) Composto ou sal do mesmo farmaceuticamente aceitável e composição farmacêutica
JP2010501584A5 (cg-RX-API-DMAC7.html)
ATE19878T1 (de) Benzimidazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JP2008531479A5 (cg-RX-API-DMAC7.html)
JP2023518777A5 (cg-RX-API-DMAC7.html)
KR970025611A (ko) 치환된 설폰이미다미드, 이의 제조방법,약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
ES2142873T3 (es) Metodo para tratar infecciones virales.
JP2022526604A5 (cg-RX-API-DMAC7.html)
JP2022137237A5 (cg-RX-API-DMAC7.html)
JP2024537784A5 (cg-RX-API-DMAC7.html)
JP2024504225A5 (cg-RX-API-DMAC7.html)
JP2024545787A5 (cg-RX-API-DMAC7.html)
JP2025508656A5 (cg-RX-API-DMAC7.html)
JP2025507180A (ja) 肺線維症治療のための薬物の調製におけるヒポキサンチン化合物の使用
JP2014511897A5 (cg-RX-API-DMAC7.html)
JPS63502179A (ja) 新規なアリ−ル誘導体類
EP1220848B1 (en) N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
GB1585963A (en) Aryl sulphur compounds
JP2022536043A5 (cg-RX-API-DMAC7.html)
ES513177A0 (es) "un procedimiento para la preparacion de pirimidin-2-onas sustituidas".
JPH08512279A (ja) 抗サイトメガロウイルス剤としてのポリアミン誘導体類